AKTS NASDAQ
Aktis Oncology, Inc.
1W: -4.7%
1M: -31.2%
3M: -30.3%
YTD: -17.3%
1Y: +18875.4%
3Y: +401.9%
5Y: +145.6%
$18.52
+0.00 (+0.00%)
Weekly Expected Move ±7.5%
$16
$17
$19
$20
$21
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$18M
Revenue
-36.1% YoY
$-64M
Net Income
+61.9% YoY
$-80M
Free Cash Flow
-72.1% YoY
74.0%
Gross Margin
-854.0%
Op. Margin
-713.5%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-29.9%
ROA-20.4%
ROIC276.4%
Valuation
P/E-17.6
P/B2.1
EV/EBITDA-19.9
Leverage
Debt/Equity0.02
Current Ratio16.33
Interest Cov.-94.9x
Quality Scores
Piotroski F5/9
Altman Z14.89
Beneish M-3.80